Hunter C. Smith - 05 Dec 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Chief Financial Officer
Signature
/s/ Hunter Smith
Issuer symbol
RYTM
Transactions as of
05 Dec 2023
Net transactions value
-$860,421
Form type
4
Filing time
07 Dec 2023, 16:16:44 UTC
Previous filing
28 Nov 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise $48,339 +7,026 +11% $6.88* 68,432 05 Dec 2023 Direct
transaction RYTM Common Stock Sale $246,360 -7,026 -10% $35.06 61,406 05 Dec 2023 Direct F1, F2
transaction RYTM Common Stock Options Exercise $137,600 +20,000 +33% $6.88* 81,406 06 Dec 2023 Direct
transaction RYTM Common Stock Sale $800,000 -20,000 -25% $40.00 61,406 06 Dec 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Stock Option (Right to Buy) Options Exercise $0 -7,026 -5.1% $0.000000 131,094 05 Dec 2023 Common Stock 7,026 $6.88 Direct F3
transaction RYTM Stock Option (Right to Buy) Options Exercise $0 -20,000 -15% $0.000000 111,094 06 Dec 2023 Common Stock 20,000 $6.88 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $35.00 to $35.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The stock options is fully vested.